Post-Facto Intimation regarding the 13th Meeting of the Committee of Creditors of Cian Healthcare Limited.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cian Healthcare, which is currently under the Corporate Insolvency Resolution Process (CIRP), held its 13th Committee of Creditors (CoC) meeting on June 21, 2025, chaired by the Resolution Professional. The CoC discussed waivers and concessions in the proposed resolution plan, tabled the draft Deed of Assignment, recorded the revised list of creditors, and approved the audited standalone financial results for the half-year and full year ended March 31, 2025. The meeting also flagged delays in consolidated audited financials, because the company's subsidiary Dr. Smith Biotech Private Limited is itself admitted under CIRP and its data handover is still incomplete. The proposed composition of the new Board of Directors (to take over once the resolution plan is approved) was noted.
The stock remains under CIRP and the resolution plan is still being shaped rather than finalised, meaning shareholders should expect continued uncertainty and likely dilution or restructuring under the final plan. No resolution approval has occurred yet, so investors should watch for the actual CoC vote on the plan and subsequent NCLT approval as the next meaningful catalysts.